Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Oncotarget|September 14, 2013
Understanding the role of NRF2-regulated miRNAs in human malignanciesNiraj M Shah, Stuart A Rushworth, Megan Y Murray, et al.
Blood|October 19, 2012
The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistanceStuart A Rushworth, Lyubov Zaitseva, Megan Y Murray, et al.
Cellular Signalling|September 15, 2012
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κBStuart A Rushworth, Kristian M Bowles, Lawrence N Barrera, et al.
Clinical Epidemiology|August 21, 2018
Low estimated glomerular filtration rate and pneumonia in stroke patients: findings from a prospective stroke registry in the East of EnglandPriya Vart, Joao H Bettencourt-Silva, Anthony K Metcalf, et al.
Scientific Reports|August 22, 2015
Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemiaGenevra Pillinger, Amina Abdul-Aziz, Lyubov Zaitseva, et al.
Cell Cycle (Georgetown, Tex.)|January 8, 2015
Ibrutinib inhibits BTK-driven NF-κB p65 activity to overcome bortezomib-resistance in multiple myelomaMegan Y Murray, Lyubov Zaitseva, Martin J Auger, et al.
Oncotarget|October 9, 2014
Ibrutinib inhibits SDF1/CXCR4 mediated migration in AMLLyubov Zaitseva, Megan Y Murray, Manar S Shafat, et al.
Biomarker Research|May 14, 2021
Venetoclax and Daratumumab combination treatment demonstrates pre-clinical efficacy in mouse models of Acute Myeloid LeukemiaJayna J Mistry, Charlotte Hellmich, Amelia Lambert, et al.
American Journal of Ophthalmology Case Reports|November 18, 2020
Erdheim-Chester Disease: Two cases from an ophthalmic perspectiveJames Brodie, Sean Zhou, Damodar Makkuni, et al.
Pageof 7